Events

Scientex conferences host a plethora of conferences in various fields but not limited to Medicine, Pharma, Health Science, Life Science, Engineering, and Technology.

SAE Media Group's inaugural Medical Devices and IVD conference will provide insight into the latest updates in EU MDR and IVDR regulations and will discuss strategies for how to best comply with these regulations. In addition, the conference will consider the evolving regulatory landscape for digital health software.

oalesce Research Group is privileged to invite you to participate in the “2nd international conference on Gynecology and Obstetrics” with the ongoing theme “Examine and Explore the advances and strategies in Gynecology and Obstetrics” scheduled on November 14-15, 2022 at Dubai, UAE.

Gain Clarity Across Next Generation Non-Invasive Testing Technologies Revolutionizing Cancer Monitoring, MRD and Earlier Detection to Support Novel Pre-Metastatic Drug Development with Maximized Access

Explore the essentials of device law and regulation and gain a comprehensive understanding of the administrative agencies that impact this industry.

This course is designed to provide the clinician and cardiac sonographer with an update on the basic concepts as well as advanced techniques when assessing cardiac disease with echocardiography.

Mayo Clinic - SSMC Transfusion Medicine Update Conference will be held on 18th-19th of November 2022, at Grand Hyatt Hotel in Abu Dhabi,UAE.

The International Bladder Cancer Update (IBCU) is a CME conference focused on the diagnosis and treatment of bladder cancer.

The Pharmacovigilance World 2022 – Virtual conference will provide a platform for the participants to discuss, share and stay updated with present state of affairs in Pharmacovigilance and Drug safety, and how it contributes to the public health. It will also allow all its participants to interact with the experts, discuss the various developments, challenges faced and innovations in the field.

Developing New Outcome Measures, Functional Biomarkers and Clinical Research Regulatory Frameworks for Disease-Modifying Therapeutics Across Neurodevelopmental and Rare, Genetic CNS Disorders